Open report — full analysis, no account required.

Sign up to generate reports and read filings that aren't on the open list.

Sign up free

Get notified when TGTX files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: TGTX TG THERAPEUTICS, INC. 8-K

TG Therapeutics reports Q1 2026 earnings results

Filed May 6, 2026 · Period ending May 6, 2026 · ~1 min read

1 key change 1 section

Key Changes

  • medium

    Company announced first quarter 2026 financial results through press release on May 6, 2026. Actual financial figures and performance metrics are contained in the attached exhibit rather than the 8-K body.

Summary

TG Therapeutics filed its routine quarterly earnings announcement for the first quarter ended March 31, 2026. This is a standard disclosure filing that biotech companies make each quarter to report financial performance. The 8-K itself serves as a wrapper document, with the actual earnings details, revenue figures, and management commentary contained in the attached press release exhibit.

Retail investors should review the press release exhibit (99.1) to understand the company's Q1 performance, including product sales, operating expenses, cash position, and any forward guidance. As a clinical-stage biotech, key metrics to watch include commercial product revenue trends, R&D spending levels, and cash runway. The next quarterly report in August will show whether any Q1 trends continue or reverse.

Section-by-Section Diff

Event · Item 9.01 — Financial Statements and Exhibits

~100 words

TG Therapeutics filed an 8-K attaching a press release dated May 6, 2026; no material event details disclosed in the filing body.

1 Added
Added Press release attachment medium

Added in current filing · verify on EDGAR →

Press release issued by TG Therapeutics, Inc., dated May 6, 2026.

The 8-K references an attached press release dated May 6, 2026 (Exhibit 99.1). The filing body does not disclose the content or subject matter of the press release, so investors must review the exhibit itself to understand the announced event.

Was this report useful?

Figures/quotes linked to EDGAR · Narrative written by AI · Jun 1, 2026 · How we verify